Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Psychosocial Treatments for Cocaine and Alcohol Dependence
NCT00218660Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 1998
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naltrexone in cocaine dependence and alcohol dependence (4 arms), sponsored by University of Pennsylvania. Primary endpoint: Alcohol and Cocaine use at 12 months. Started Apr 1998; status: completed.
02
Drugs
naltrexone
03
Conditions
cocaine dependencealcohol dependence
Beyond the preview
Go deeper on NCT00218660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218660.